2019-09 | Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT | 윤채옥 |
2011-09 | Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12R beta(2) or IL-18R alpha | 윤채옥 |
2015-07 | Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy | 윤채옥 |
2017-01 | Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model | 윤채옥 |
2015-12 | Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model | 윤채옥 |
2016-12 | Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function adn enhances antitumor efficacy. | 윤채옥 |
2013-07 | Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-a-Co-Producing T Cell-Mediated Antitumor Immunity | 윤채옥 |
2017-06 | Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer | 윤채옥 |
2020-11 | Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials | 윤채옥 |
2020-04 | Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells | 윤채옥 |
2017-08 | Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy | 윤채옥 |
2021-08 | Optimizing Active Tumor Targeting Biocompatible Polymers for Efficient Systemic Delivery of Adenovirus | 윤채옥 |
2011-08 | Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF | 윤채옥 |
2021-02 | Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective | 윤채옥 |
2019-07 | Overcoming the limitations of locally administered oncolytic virotherapy | 윤채옥 |
2022-03 | A pH-and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery | 윤채옥 |
2015-05 | pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis | 윤채옥 |
2019-10 | Physically crosslinked injectable hydrogels for long-term delivery of oncolytic adenoviruses for cancer treatment | 윤채옥 |
2021-01 | Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic | 윤채옥 |
2015-12 | Polymeric oncolytic adenovirus for cancer gene therapy | 윤채옥 |
2022-02 | Polymeric Systems for Cancer Immunotherapy: A Review | 윤채옥 |
2021-12 | Polypeptide-Based K+Ionophore as a Strong Immunogenic Cell Death Inducer for Cancer Immunotherapy | 윤채옥 |
2015-11 | Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus | 윤채옥 |
2015-12 | Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model | 윤채옥 |
2018-01 | Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer | 윤채옥 |
2018-05 | Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues | 윤채옥 |
2012-08 | A proteoliposome containing apolipoprotein A-I mutant (V156K) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice | 윤채옥 |
2015-08 | QUANTITATIVE IMPACT OF IMMUNOMODULATION VERSUS ONCOLYSIS WITH CYTOKINE-EXPRESSING VIRUS THERAPEUTICS | 윤채옥 |
2013-02 | Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers | 윤채옥 |
2016-06 | Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy | 윤채옥 |